CSIMarket
 
Indivior Pharmaceuticals Inc   (NASDAQ: INDV)
 

Indivior Pharmaceuticals Inc's Suppliers Performance

INDV's Supply Chain




 
INDV Costs vs Sales of Suppliers Growth Indivior Pharmaceuticals Inc's cost of sales deteriorated by -3.85 % year on year, sequentially cost of sales grew by 25 % in Q2.

• More on INDV Suppliers



Indivior Pharmaceuticals Inc's cost of sales deteriorated by -3.85 % year on year, sequentially cost of sales grew by 25 % in Q2.

• More on INDV Suppliers




Indivior Pharmaceuticals Inc's Comment on Supply Chain


The company sources raw materials, components, and active pharmaceutical ingredients (APIs) from the U.K., European Union, Australia, Japan, and the Philippines. Its primary APIs are produced at a manufacturing plant in the U.K., which currently benefits from a tariff exemption for at least three years under a recent U.K./U.S. agreement. Finished products are exported from the United States to Canada and Australia. The company faces challenges including tariffs, supply chain disruptions, labor shortages, and inflation, which may affect its profitability and operations. Regulatory and contractual constraints limit its ability to mitigate tariffs or increase prices. Economic and geopolitical conditions, particularly in the United States, have a significant impact on the company's financial performance.

Indivior Pharmaceuticals Inc's Comment on Supply Chain


The company sources raw materials, components, and active pharmaceutical ingredients (APIs) from the U.K., European Union, Australia, Japan, and the Philippines. Its primary APIs are produced at a manufacturing plant in the U.K., which currently benefits from a tariff exemption for at least three years under a recent U.K./U.S. agreement. Finished products are exported from the United States to Canada and Australia. The company faces challenges including tariffs, supply chain disruptions, labor shortages, and inflation, which may affect its profitability and operations. Regulatory and contractual constraints limit its ability to mitigate tariffs or increase prices. Economic and geopolitical conditions, particularly in the United States, have a significant impact on the company's financial performance.







INDV's vs. Suppliers, Data

(Revenue and Income for Trailing 12 Months, in Millions of $, except Employees)



COMPANY NAME MARKET CAP REVENUES INCOME EMPLOYEES
Indivior Pharmaceuticals Inc 4,465.24 1,333.00 356.00 1,000
SUBTOTAL 0.00 0.00 0.00 -


Sources: Indivior Pharmaceuticals Inc 's official press releases and regulatory filings; CSIMarket.com's supply-chain research; and the financial filings and press releases of other companies cited in this report.
Updated on:
For your research, we’ve provided nine additional tables on Indivior Pharmaceuticals Inc ’s suppliers.
You can find them in the navigation menu under Suppliers.
To download the tables, please subscribe.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.